Streetbeat News

Products Services

FATE

FATE Therapeutics reported a narrower-than-expected loss for Q3 2024, driven by higher revenues. The company's innovative pipeline is a key focus.

Portfolio Pulse from

November 13, 2024 | 5:30 pm

AAAU

Gold and silver prices remain steady as a strong US dollar index (USDX) limits buyer interest. The market is influenced by the strength of the USDX, which affects the attractiveness of these commodities.

Portfolio Pulse from

November 13, 2024 | 5:15 pm

BABA

Alibaba's upcoming Q2 2025 earnings report presents a potential buy opportunity due to its AI-driven growth, international expansion, and strategic cloud pricing, despite challenges in China.

Portfolio Pulse from

November 13, 2024 | 5:15 pm

PSTG

Pure Storage has announced a strategic investment and technology partnership with CoreWeave to enhance large-scale AI cloud services. This collaboration aims to accelerate innovation in AI cloud services.

Portfolio Pulse from

November 13, 2024 | 5:15 pm

GMED

Globus Medical is experiencing significant growth in its product portfolio, including expandables, biologics, MIS screws, 3D printed implants, and cervical offerings. This expansion is expected to positively impact GMED stock.

Portfolio Pulse from

November 13, 2024 | 5:15 pm

ROLR

High Roller Technologies, Inc. (NYSE American: ROLR) has been awarded Best Player Retention 2024 at the SiGMA Europe B2C Awards, highlighting its success in building a loyal player community.

Portfolio Pulse from

November 13, 2024 | 5:15 pm

XENE

Xenon Pharmaceuticals (XENE) reported a narrower-than-expected loss for Q3 2024. The company's development programs for azetukalner in epilepsy and major depressive disorder (MDD) are progressing well.

Portfolio Pulse from

November 13, 2024 | 5:15 pm

CAH

Cardinal Health (CAH) has announced two strategic acquisitions aimed at bolstering its multi-specialty and at-Home Solutions businesses. This move is expected to enhance its market position and drive growth.

Portfolio Pulse from

November 13, 2024 | 5:15 pm

PII

Polaris Inc. has launched Polaris Adventures Elite, a suite of over 20 tools designed to assist small outdoor experience businesses in streamlining operations. This initiative aims to enhance efficiency and improve customer experiences.

Portfolio Pulse from

November 13, 2024 | 5:15 pm

SWTX

SpringWorks Therapeutics reported mixed Q3 2024 results with a narrower-than-expected loss but missed revenue expectations. The company's newly approved desmoid tumor drug, Ogsiveo, had a strong launch.

Portfolio Pulse from

November 13, 2024 | 5:15 pm